Lee S, Kim J, Jang I, Jo S, Lee S, Oh S
Int J Mol Sci. 2024; 25(19).
PMID: 39408655
PMC: 11476788.
DOI: 10.3390/ijms251910326.
Ma H, Shi L, Zheng J, Zeng L, Chen Y, Zhang S
BMC Cancer. 2024; 24(1):1222.
PMID: 39354417
PMC: 11446097.
DOI: 10.1186/s12885-024-12952-w.
Sugawara S, Lee E, Craemer M, Pruitt A, Balachandran H, Gressens S
AIDS Res Hum Retroviruses. 2024; 40(11):631-636.
PMID: 39041622
PMC: 11631794.
DOI: 10.1089/AID.2023.0114.
Sugawara S, Hueber B, Woolley G, Terry K, Kroll K, Manickam C
PLoS Pathog. 2023; 19(9):e1011629.
PMID: 37669308
PMC: 10503717.
DOI: 10.1371/journal.ppat.1011629.
Sabag B, Levy M, Kivelevitz J, Dashevsky N, Ben-Shmuel A, Puthenveetil A
Cancers (Basel). 2022; 14(15).
PMID: 35954420
PMC: 9367451.
DOI: 10.3390/cancers14153756.
The Role of the Cytoskeleton in Regulating the Natural Killer Cell Immune Response in Health and Disease: From Signaling Dynamics to Function.
Ben-Shmuel A, Sabag B, Biber G, Barda-Saad M
Front Cell Dev Biol. 2021; 9:609532.
PMID: 33598461
PMC: 7882700.
DOI: 10.3389/fcell.2021.609532.
Research Progress on NK Cell Receptors and Their Signaling Pathways.
Chen Y, Lu D, Churov A, Fu R
Mediators Inflamm. 2020; 2020:6437057.
PMID: 32774149
PMC: 7396059.
DOI: 10.1155/2020/6437057.
Inducible MyD88/CD40 synergizes with IL-15 to enhance antitumor efficacy of CAR-NK cells.
Wang X, Jasinski D, Medina J, Spencer D, Foster A, Bayle J
Blood Adv. 2020; 4(9):1950-1964.
PMID: 32384544
PMC: 7218419.
DOI: 10.1182/bloodadvances.2020001510.
NK cell recognition of hematopoietic cells by SLAM-SAP families.
Chen S, Dong Z
Cell Mol Immunol. 2019; 16(5):452-459.
PMID: 30911116
PMC: 6474203.
DOI: 10.1038/s41423-019-0222-4.
Natural Killer Cells: Development, Maturation, and Clinical Utilization.
Abel A, Yang C, Thakar M, Malarkannan S
Front Immunol. 2018; 9:1869.
PMID: 30150991
PMC: 6099181.
DOI: 10.3389/fimmu.2018.01869.
Strategies to enhance NK cell function for the treatment of tumors and infections.
Freund-Brown J, Chirino L, Kambayashi T
Crit Rev Immunol. 2018; 38(2):105-130.
PMID: 29953390
PMC: 6343663.
DOI: 10.1615/CritRevImmunol.2018025248.
Natural killer cell cytotoxicity and its regulation by inhibitory receptors.
Kumar S
Immunology. 2018; 154(3):383-393.
PMID: 29512837
PMC: 6002213.
DOI: 10.1111/imm.12921.
Actin retrograde flow controls natural killer cell response by regulating the conformation state of SHP-1.
Matalon O, Ben-Shmuel A, Kivelevitz J, Sabag B, Fried S, Joseph N
EMBO J. 2018; 37(5).
PMID: 29449322
PMC: 5830919.
DOI: 10.15252/embj.201696264.
In silico modeling identifies CD45 as a regulator of IL-2 synergy in the NKG2D-mediated activation of immature human NK cells.
Mukherjee S, Jensen H, Stewart W, Stewart D, Ray W, Chen S
Sci Signal. 2017; 10(485).
PMID: 28655861
PMC: 5556952.
DOI: 10.1126/scisignal.aai9062.
Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an "Off-the-Shelf Immunotherapy" for Improvement in Cancer Treatment.
Oberschmidt O, Kloess S, Koehl U
Front Immunol. 2017; 8:654.
PMID: 28649246
PMC: 5465249.
DOI: 10.3389/fimmu.2017.00654.
Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy.
Kwon H, Kim N, Kim H
Exp Mol Med. 2017; 49(3):e311.
PMID: 28360428
PMC: 5382566.
DOI: 10.1038/emm.2017.42.
TREM2 in CNS homeostasis and neurodegenerative disease.
Painter M, Atagi Y, Liu C, Rademakers R, Xu H, Fryer J
Mol Neurodegener. 2015; 10:43.
PMID: 26337043
PMC: 4560063.
DOI: 10.1186/s13024-015-0040-9.
A signaling network stimulated by β2 integrin promotes the polarization of lytic granules in cytotoxic cells.
Zhang M, March M, Lane W, Long E
Sci Signal. 2014; 7(346):ra96.
PMID: 25292215
PMC: 4205566.
DOI: 10.1126/scisignal.2005629.
Recognition of tumors by the innate immune system and natural killer cells.
Marcus A, Gowen B, Thompson T, Iannello A, Ardolino M, Deng W
Adv Immunol. 2014; 122:91-128.
PMID: 24507156
PMC: 4228931.
DOI: 10.1016/B978-0-12-800267-4.00003-1.
NKG2D triggers cytotoxicity in murine epidermal γδ T cells via PI3K-dependent, Syk/ZAP70-independent signaling pathway.
Ibusuki A, Kawai K, Yoshida S, Uchida Y, Nitahara-Takeuchi A, Kuroki K
J Invest Dermatol. 2013; 134(2):396-404.
PMID: 23962808
DOI: 10.1038/jid.2013.353.